G0420 Botanicals by a Novel Technology

Have a look at our Introduction and Brochure for a description of our consultancy work.

The objective of the study was to assist the client in utilising its gene discovery technologies and capabilities in the development of commercial research collaborations with industry players in the food, feed, cosmetics and/or pharmaceutical industries by identifying primary and secondary metabolites of commercial interest and significance to those industries that are amenable to production in plants.

Botantical Compounds reviewed in respect of uses, market size and major outlets included:

Alkaloids

Anthocyanins

Carotenoids

  • Astaxanthin
  • Beta-Carotene
  • Lycopene
  • Lutein
  • Zeaxanthin

Flavenoids

Isoflavones

Others

  • Co-enzyme Q10

The client had developed a technology allowing it to identify genes controlling the production of commercially important secondary metabolite compounds.

The study contained a summary of the opportunities to recruit research collaborations for gene discovery using the client’s technology.

The study reviewed the needs of the food, feed, cosmetics and/or pharmaceutical industries for primary and secondary metabolites for use as nutraceuticals, nutrients, natural colours and flavourings, other flavour and fragrance applications. The pharmaceutical industry also uses some plant alkaloids, for example, nicotine in OTC products, and menthol in some OTC digestive remedies.

Of particular importance was a review of the key problems or limiting aspects of the production of biological compounds within those sectors, for example security of supply, product consistency and product cost.

The study reviewed what the products were and which companies were interested in collaboration.

The study provided a strategy for the client in respect of who it should approach and how.

CPL Gallery

Previous Image
Next Image